Shandong Dongyue Organosilicon Materials Co., Ltd.
SZSE:300821.SZ
8.36 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,150.65 | 4,801.468 | 6,734 | 4,333.219 | 2,503.32 | 2,733.151 | 3,400.873 | 2,440.854 | 1,692.312 | 1,454.222 |
| Cost of Revenue
| 4,827.716 | 4,789.969 | 5,777.565 | 2,713.059 | 1,931.414 | 1,976.292 | 2,135.83 | 1,762.055 | 1,483.217 | 1,389.808 |
| Gross Profit
| 322.933 | 11.499 | 956.435 | 1,620.16 | 571.906 | 756.859 | 1,265.042 | 678.798 | 209.095 | 64.415 |
| Gross Profit Ratio
| 0.063 | 0.002 | 0.142 | 0.374 | 0.228 | 0.277 | 0.372 | 0.278 | 0.124 | 0.044 |
| Reseach & Development Expenses
| 164.155 | 233.534 | 316.578 | 231.821 | 185.97 | 85.598 | 44.541 | 2.962 | 2.087 | 2.209 |
| General & Administrative Expenses
| 11.174 | 53.231 | 17.037 | 12.124 | 9.351 | 12.892 | 116.119 | 9.6 | 39.262 | 35.271 |
| Selling & Marketing Expenses
| 7.089 | 19.734 | 21.55 | 21.69 | 74.812 | 73.881 | 67.116 | 62.372 | 63.077 | 49.666 |
| SG&A
| 18.264 | 72.764 | 38.587 | 33.814 | 84.163 | 86.773 | 183.235 | 71.972 | 102.339 | 84.937 |
| Other Expenses
| 43.944 | 0 | 57.293 | 46.905 | 35.864 | 71.337 | -29.506 | -110.605 | -11.943 | 18.139 |
| Operating Expenses
| 226.363 | 334.955 | 412.458 | 312.54 | 305.997 | 243.708 | 333.91 | 145.955 | 113.029 | 90.827 |
| Operating Income
| 96.571 | -316.94 | 551.494 | 1,326.917 | 297.237 | 530.586 | 935.854 | 510.666 | 72.456 | -53.478 |
| Operating Income Ratio
| 0.019 | -0.066 | 0.082 | 0.306 | 0.119 | 0.194 | 0.275 | 0.209 | 0.043 | -0.037 |
| Total Other Income Expenses Net
| -23.682 | 17.949 | -9.497 | -12.235 | 51.226 | 13.914 | -29.506 | -110.605 | -35.076 | -8.393 |
| Income Before Tax
| 72.888 | -298.991 | 541.996 | 1,314.682 | 305.902 | 524.669 | 906.349 | 400.06 | 60.513 | -35.34 |
| Income Before Tax Ratio
| 0.014 | -0.062 | 0.08 | 0.303 | 0.122 | 0.192 | 0.267 | 0.164 | 0.036 | -0.024 |
| Income Tax Expense
| 20.061 | -27.433 | 31.014 | 164.048 | 25.17 | -28.757 | 242.881 | 89.998 | 12.783 | 27.6 |
| Net Income
| 56.762 | -271.125 | 511.119 | 1,150.634 | 280.732 | 553.425 | 663.467 | 310.062 | 60.513 | -35.34 |
| Net Income Ratio
| 0.011 | -0.056 | 0.076 | 0.266 | 0.112 | 0.202 | 0.195 | 0.127 | 0.036 | -0.024 |
| EPS
| 0.05 | -0.23 | 0.43 | 0.96 | 0.23 | 0.46 | 0.74 | 0.34 | 0.07 | -0.04 |
| EPS Diluted
| 0.05 | -0.23 | 0.43 | 0.96 | 0.23 | 0.46 | 0.74 | 0.34 | 0.07 | -0.04 |
| EBITDA
| 429.314 | 32.201 | 808.414 | 1,434.147 | 427.261 | 643.171 | 1,024.821 | 554.707 | 223.175 | 108.465 |
| EBITDA Ratio
| 0.083 | 0.007 | 0.12 | 0.331 | 0.171 | 0.235 | 0.301 | 0.227 | 0.132 | 0.075 |